Crystal form of an organic compound and process for the preparation thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9221870
APP PUB NO 20120142655A1
SERIAL NO

13387783

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel crystalline Form II of 17α-acetoxy-21-methoxy-11β-[4-N,N-dimethylaminophenyl]-19-norpregna-4,9-diene-3,20-dione, (also known as CDB-4124), processes for the preparation thereof and pharmaceutical compositions comprising it. Form II can be crystallized from different medium such as esters of C1-C4 alcohols and carboxylic acids, ketones, cyclohexane, acetonitrile, dimethylformamide, dimethyl sulfoxide, water and any mixture thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RICHTER GEDEON NYRTGYÖMRÖI ÚT 19-21 BUDAPEST H-1103

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Balázs, Attila Kerepes, HU 2 1
Csörgei, János Budapest, HU 8 3
Demeter, Ádám Budapest, HU 5 1
Sánta, Csaba Budapest, HU 7 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 29, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00